If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,086.00    -32.00 (-2.86%)
Bid:
1,080.00
Ask:
1,086.00
Spread: 6.00 (0.556%)
Market Cap: £371.82m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement

17 Nov 2020 07:00

RNS Number : 4950F
Craneware plc
17 November 2020
 

17 November 2020

 

Craneware plc

("Craneware" or the "Company")

 

AGM Statement

 

 

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting taking place at 10am today. The AGM will be run as a "closed meeting", with only the minimum required quorum of two shareholders being present as is necessary to enable the formal business of the meeting to be conducted.

 

The first four months of this fiscal year saw a return to strong sales growth, considerably ahead of the equivalent period of the prior year. Results are ahead of management expectations for this stage in the year and, we expect revenues and adjusted EBITDA for the Interim period to 31 December 2020 to be ahead of the equivalent period in the prior year, building the foundation for a return to double-digit growth in the future. We look forward to providing further details within our Trading Update for the 6 months ended 31 December 2020.

 

Our Value Cycle offering, delivered via our cloud-based Trisus platform, continues to resonate with the leadership teams of US hospitals. Trisus provides the means to collect, analyse, compare, verify, and correct their data, so they can improve the financial and operational performance of their hospitals, while improving patient outcomes.

 

With each hospital that joins the platform, Trisus becomes more powerful. Through the recent beta launches of the Trisus (cloud) versions of our core offerings, Chargemaster Toolkit and Pharmacy Chargelink, and our four live Trisus native cloud applications, we now have multiple means by which new and existing customers can join the Trisus Community, providing them with a gateway to the wider benefits the platform can provide.

 

We continue to see substantial new opportunities entering the sales pipeline and the Board is confident in the continued strong performance of the business.

 

 For further information, please contact:

Craneware plc

Peel Hunt 

Investec Bank

Alma

(NOMAD & Joint Broker)

(Joint Broker)

(Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)203 405 0205

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Sebastian Lawrence

Robyn Fisher

Andrew Clark

Henry Reast

Helena BogleJoe Pederzolli

About Craneware

 

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMBIBDBLGBDGGL
Date   Source Headline
22nd Apr 20104:08 pmRNSHolding(s) in Company-Amendment
22nd Apr 20102:27 pmRNSHolding(s) in Company
21st Apr 20103:41 pmRNSDirectors Shareholding
21st Apr 20107:00 amRNSReseller Agreement with Premier
15th Apr 20104:12 pmRNSBlocklisting Interim Review
5th Mar 201011:02 amRNSDividend Currency Election
22nd Feb 20107:01 amRNSContract Win
22nd Feb 20107:00 amRNSInterim Results
4th Feb 20105:17 pmRNSHolding(s) in Company
25th Jan 201012:49 pmRNSHolding(s) in Company
18th Jan 20107:00 amRNSTrading Update
23rd Dec 20097:01 amRNSGrant of Options
22nd Dec 20097:00 amRNSIntermountain Healthcare Selects Craneware
19th Nov 20093:11 pmRNSResult of AGM
19th Nov 20097:00 amRNSAGM Statement
6th Nov 20091:41 pmRNSDividend Currency Election
21st Oct 20092:46 pmRNSBlocklisting Interim Review
20th Oct 20097:00 amRNSNotice of AGM
1st Oct 200912:39 pmRNSPosting of Annual Report and Accounts
25th Sep 20097:00 amRNSContract Win
18th Sep 200911:51 amRNSDirector/PDMR Shareholding
7th Sep 20097:00 amRNSFinal Results
26th Aug 20097:00 amRNSNotice of Results
6th May 20097:00 amRNSDividend Currency Election
27th Apr 20097:00 amRNSAppointment of Non-Executive Director
16th Apr 200912:44 pmRNSBlocklisting Interim Review
14th Apr 20097:00 amRNSAgreement with US healthcare alliance
26th Mar 200911:01 amRNSDirector/PDMR Shareholding
26th Mar 20097:00 amRNSDividend Declaration
27th Feb 20092:43 pmRNSDirector Shareholding
23rd Feb 20097:00 amRNSInterim Results
11th Feb 20096:23 pmRNSHolding(s) in Company
29th Jan 20097:00 amRNSNotice of Results
13th Jan 20097:00 amRNSTrading Update and Contract Win
19th Nov 200811:10 amRNSHolding(s) in Company
13th Nov 20085:43 pmRNSHolding(s) in Company
7th Nov 20083:04 pmRNSDividend Currency Election
4th Nov 20087:00 amRNSAGM Statement
31st Oct 20081:43 pmRNSHolding(s) in Company
31st Oct 20081:42 pmRNSHolding(s) in Company
24th Oct 200811:28 amRNSBlocklisting Interim Review
13th Oct 20087:00 amRNSNotice of AGM
16th Sep 20085:20 pmRNSHolding(s) in Company
15th Sep 20083:58 pmRNSHolding(s) in Company
9th Sep 20087:01 amRNSAppointment of a Director
9th Sep 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSTrading Statement
26th Jun 20088:32 amRNSRe Contract
25th Jun 20083:51 pmRNSHolding(s) in Company
24th Jun 20088:34 amRNSContract with CHE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.